1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 TOP-DOWN APPROACH
2.2 BOTTOM-UP APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL ORTHOPEDIC TAPES  MARKET SNAPSHOT
3.2 GLOBAL ORTHOPEDIC TAPES  MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT TYPE DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL ORTHOPEDIC TAPES , BY PRODUCT TYPE
5.1 OVERVIEW
5.2 ORFICAST
5.3 CELLONA PLASTER- OF- PARIS
5.4 DELTA- LITE PLUS
5.5 CELLACAST XRTA CAST TAPES
5.6 TECHFORM PREMIUM
5.7 OTHERS
6 GLOBAL ORTHOPEDIC TAPES , BY MATERIAL TYPE
6.1 OVERVIEW
6.2 PLASTIC
6.3 FABRIC
6.4 ELASTIC
6.5 OTHERS
7 GLOBAL ORTHOPEDIC TAPES MARKET, BY APPLICATION
7.1 SURGICAL WOUND TREATMENT
7.2 BURN INJURY
7.3 TRAUMATIC WOUND TREATMENT
7.4 SPORTS INJURY
7.5 OTHERS
8 GLOBAL ORTHOPEDIC TAPES MARKET, BY END-USER
8.1 OVERVIEW
8.2 HEALTHCARE CENTER
8.3 HOMECARE
8.4 AMBULATORY SURGERY CENTER
9 GLOBAL ORTHOPEDIC TAPES  MARKET, BY GEOGRAPHY
9.1 NORTH AMERICA
9.1.1 MARKET DYNAMICS
9.1.1.1 DRIVERS
9.1.1.2 RESTRAINTS
9.1.1.3 OPPORTUNITY
9.1.2 U.S.
9.1.3 CANADA
9.1.4 MEXICO
9.2 EUROPE
9.2.1 MARKET DYNAMICS
9.2.1.1 DRIVERS
9.2.1.2 RESTRAINTS
9.2.1.3 OPPORTUNITY
9.2.2 U.K.
9.2.3 FRANCE
9.2.4 GERMANY
9.2.5 SPAIN
9.2.6 REST OF EUROPE
9.3 ASIA PACIFIC
9.3.1 MARKET DYNAMICS
9.3.1.1 DRIVERS
9.3.1.2 RESTRAINTS
9.3.1.3 OPPORTUNITY
9.3.2 INDIA
9.3.3 CHINA
9.3.4 JAPAN
9.3.5 REST OF ASIA PACIFIC
9.4 MIDDLE EAST AND AFRICA
9.4.1 MARKET DYNAMICS
9.4.1.1 DRIVERS
9.4.1.2 RESTRAINTS
9.4.1.3 OPPORTUNITY
9.4.2 SOUTH AFRICA
9.4.3 REST OF MIDDLE EAST AND AFRICA
9.5 LATIN AMERICA
9.5.1 MARKET DYNAMICS
9.5.1.1 DRIVERS
9.5.1.2 RESTRAINTS
9.5.1.3 OPPORTUNITY
9.5.2 BRAZIL
9.5.3 REST OF LATIN AMERICA
10 GLOBAL ORTHOPEDIC TAPES  MARKET, BY COMPANY
10.1 INTRODUCTION
10.2 B. BRAUN MELSUNGEN AG
10.2.1 BUSINESS OVERVIEW
10.2.2 PRODUCT TYPES & SERVICES
10.2.3 KEY STRATEGY
10.2.4 RECENT DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.3 CARDINAL HEALTH INC.
10.3.1 BUSINESS OVERVIEW
10.3.2 PRODUCT TYPES & SERVICES
10.3.3 KEY STRATEGY
10.3.4 RECENT DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.4 DERMA SCIENCES INC.
10.4.1 BUSINESS OVERVIEW
10.4.2 PRODUCT TYPES & SERVICES
10.4.3 KEY STRATEGY
10.4.4 RECENT DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.5 JOHNSON & JOHNSON
10.5.1 BUSINESS OVERVIEW
10.5.2 PRODUCT TYPES & SERVICES
10.5.3 KEY STRATEGY
10.5.4 RECENT DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.6 MOLNLYCKE HEALTH CARE AB
10.6.1 BUSINESS OVERVIEW
10.6.2 PRODUCT TYPES & SERVICES
10.6.3 KEY STRATEGY
10.6.4 RECENT DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.7  MEDTRONIC
10.7.1 BUSINESS OVERVIEW
10.7.2 PRODUCT TYPES & SERVICES
10.7.3 KEY STRATEGY
10.7.4 RECENT DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.8 MEDLINE INDUSTRIES
10.8.1 BUSINESS OVERVIEW
10.8.2 PRODUCT TYPES & SERVICES
10.8.3 KEY STRATEGY
10.8.4 RECENT DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.9 PAUL HARTMANN AG
10.9.1 BUSINESS OVERVIEW
10.9.2 PRODUCT TYPES & SERVICES
10.9.3 KEY STRATEGY
10.9.4 RECENT DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.10 ZIMMER BIOMET
10.10.1 BUSINESS OVERVIEW
10.10.2 PRODUCT TYPES & SERVICES
10.10.3 KEY STRATEGY
10.10.4 RECENT DEVELOPMENTS
10.10.5 SWOT ANALYSIS